Anne O’Dea

1.6k citations

45 papers · 716 indexed · h-index 14

Impact in

Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics

Papers in ⓘ

Oncology 27
- Cancer Treatment and Pharmacology 9
- Cancer Immunotherapy and Biomarkers 7
- Cancer Cells and Metastasis 5
- HER2/EGFR in Cancer Research 5
Cancer Research 23
- Breast Cancer Treatment Studies 15
- Cancer Genomics and Diagnostics 10

Co-authors: Qamar J. Khan (32 shared papers)Priyanka Sharma (32 shared papers)Bruce F. Kimler (17 shared papers)Carol J. Fabian (7 shared papers)Jennifer R. Klemp (7 shared papers)Pavan S. Reddy (2 shared papers)Lauren Nye (21 shared papers)Jamie L. Wagner (9 shared papers)
Journals: Journal of Clinical Oncology (20 papers)Cancer Research (7 papers)Nature Cancer (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States Australia Belgium

In The Last Decade

Anne O’Dea

38 papers receiving 704 citations

Peers

Countries citing papers authored by Anne O’Dea

Since Specialization

Citations

This map shows the geographic impact of Anne O’Dea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne O’Dea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne O’Dea more than expected).

Fields of papers citing papers by Anne O’Dea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne O’Dea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne O’Dea. The network helps show where Anne O’Dea may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne O’Dea, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne O’Dea Line = papers co-authored together Anne O’Dea links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer Breast Cancer Research and Treatment ·Qamar J. Khan, Pavan S. Reddy, Bruce F. Kimler, Priyanka Sharma, S. Baxa, Anne O’Dea, Jennifer R. Klemp, Carol J. Fabian	2009	146
2	Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer JAMA Oncology ·Priyanka Sharma, Shane R. Stecklein, Rachel Yoder, Joshua M. Staley, Kelsey Schwensen, Anne O’Dea, Lauren Nye, Deepti Satelli, Gregory Crane, Rashna Madan, Maura O’Neil, Jamie L. Wagner, Kelsey E. Larson, Christa Balanoff, Lyndsey J. Kilgore, Milind A. Phadnis, Andrew K. Godwin, Roberto Salgado, Qamar J. Khan, Joyce O’Shaughnessy	2023	78
3	Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors Journal of Oncology ·Qamar J. Khan, Anne O’Dea, Priyanka Sharma	2010	63
4	Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions Annals of Surgical Oncology ·Lyndsey J. Kilgore, Sabrina S. Korentager, Amanda N. Hangge, Amanda L. Amin, Christa Balanoff, Kelsey E. Larson, Melissa P. Mitchell, John G. Chen, Emily Burgen, Qamar J. Khan, Anne O’Dea, Lauren Nye, Priyanka Sharma, Jamie L. Wagner	2018	62
5	A randomized, phase II trial of fulvestrant or exemestane with or without ribociclib after progression on anti-estrogen therapy plus cyclin-dependent kinase 4/6 inhibition (CDK 4/6i) in patients (pts) with unresectable or hormone receptor–positive (HR+), HER2-negative metastatic breast cancer (MBC): MAINTAIN trial. Journal of Clinical Oncology ·Kevin Kalinsky, Melissa Accordino, Codruța Chiuzan, Prabhjot S. Mundi, Meghna S. Trivedi, Yelena Novik, Amy Tiersten, George Raptis, Lea Baer, Sun Young Oh, Amelia Zelnak, Kari B. Wisinski, Eleni Andreopoulou, William J. Gradishar, Erica Stringer-Reasor, Sonya Reid, Anne O’Dea, Ruth O’Regan, Katherine D. Crew, Dawn L. Hershman	2022	53
6	Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial). Journal of Clinical Oncology ·Qamar J. Khan, Anne O’Dea, Aditya Bardia, Kevin Kalinsky, Kari B. Wisinski, Ruth O’Regan, Yuan Yuan, X. Cynthia, Mohammad Jahanzeb, Meghna S. Trivedi, Laura M. Spring, Issam Makhoul, Jamie L. Wagner, Onalisa Winblad, Amanda L. Amin, Sibel Blau, Gregory Crane, Manana Elia, Mia Hard, Priyanka Sharma	2020	47
7	Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy Nature Cancer ·Jason I. Griffiths, Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia, Meghna S. Trivedi, Kevin Kalinsky, Kari B. Wisinski, Ruth O’Regan, Issam Makhoul, Laura M. Spring, Aditya Bardia, Frederick R. Adler, Adam L. Cohen, Jeffrey T. Chang, Qamar J. Khan, Andrea H. Bild	2021	41
8	Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT). Journal of Clinical Oncology ·Priyanka Sharma, Shane R. Stecklein, Rachel Yoder, Joshua M. Staley, Kelsey Schwensen, Anne O’Dea, Lauren Nye, Manana Elia, Deepti Satelli, Gregory Crane, Rashna Madan, Maura O’Neil, Jamie L. Wagner, Kelsey E. Larson, Christa Balanoff, Milind A. Phadnis, Andrew K. Godwin, Roberto Salgado, Qamar J. Khan, Joyce O’Shaughnessy	2022	37
9	Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer Breast Cancer Research ·Qamar J. Khan, Bruce F. Kimler, Anne O’Dea, Carola M. Zalles, Priyanka Sharma, Carol J. Fabian	2007	32
10	Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer. Journal of Clinical Oncology ·Priyanka Sharma, Vandana G. Abramson, Anne O’Dea, Harsh B. Pathak, Ziyan Y. Pessetto, Yen Y. Wang, Karissa Finke, Marc Hoffmann, Manana Elia, Sharon L. Lewis, Jecinta Scott, Jilliann De Jong, Julia Urban, Jaimie Heldstab, Stephanie LaFaver, Stephen K. Williamson, Greg Reed, Bruce F. Kimler, Qamar J. Khan, Andrew K. Godwin	2018	21
11	Patient Satisfaction of BRCA1/2 Genetic Testing by Women at High Risk for Breast Cancer Participating in a Prevention Trial Familial Cancer ·Jennifer R. Klemp, Anne O’Dea, Carolyn Chamberlain, Carol J. Fabian	2005	19
12	ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease npj Breast Cancer ·Shane R. Stecklein, Bruce F. Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M. Staley, Qamar J. Khan, Anne O’Dea, Lauren Nye, Manana Elia, Jaimie Heldstab, Trisha Home, Stephen Hyter, Kamilla Isakova, Harsh B. Pathak, Andrew K. Godwin, Priyanka Sharma	2023	16
13	Romidepsin (HDACi) plus cisplatin and nivolumab triplet combination in patients with metastatic triple negative breast cancer (mTNBC). Journal of Clinical Oncology ·Priyanka Sharma, Vandana G. Abramson, Anne O’Dea, Lauren Nye, Ingrid A. Mayer, Gregory Crane, Manana Elia, Rachel Yoder, Joshua M. Staley, Kelsey Schwensen, Karissa Finke, Jaimie Heldstab, Stephanie LaFaver, Micki Prager, Stephen K. Williamson, Milind A. Phadnis, Gregory A. Reed, Bruce F. Kimler, Qamar J. Khan, Andrew K. Godwin	2021	16
14	Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women. PubMed ·Ossama Tawfik, Keisha Davis, Bruce F. Kimler, Marilyn Davis, Stephanie Hull, Fang Fan, Qamar J. Khan, Anne O’Dea, P. Thomas	2010	15
15	Randomized trial of fixed dose capecitabine compared to standard dose capecitabine in metastatic breast cancer: The X-7/7 trial. Journal of Clinical Oncology ·Qamar J. Khan, Colleen Bohnenkamp, Taylor Monson, Holly E. Smith, Milind A. Phadnis, Vinay Raja, Manana Elia, Anne O’Dea, Gregory Crane, Mark Robert Fesen, Lauren Nye, Maureen K. Sheehan, Robert Pluenneke, Raed Moh’d Taiseer Al-Rajabi, Joaquina Baranda, Anup Kasi, Richard McKittrick, Laura E. Mitchell, Stephanie LaFaver, Priyanka Sharma	2023	7
16	Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast cancer (NCT02413320). Journal of Clinical Oncology ·Priyanka Sharma, Bruce F. Kimler, Anne O’Dea, Lauren Nye, Yen Y. Wang, Rachel Yoder, Lindsey Prochaska, Jamie L. Wagner, Amanda L. Amin, Kelsey E. Larson, Christa Balanoff, Manana Elia, Gregory Crane, Sheshadri Madhusudhana, Marc Hoffmann, Maureen K. Sheehan, Robert R. Rodriguez, Roy A. Jensen, Andrew K. Godwin, Qamar J. Khan	2019	7
17	Pupillary response: cognitive effort for breast cancer survivors Supportive Care in Cancer ·Jamie Myers, Melike Kahya, Melissa P. Mitchell, Junqiang Dai, Jianghua He, Sanghee Moon, Kevin Hamilton, Mary Valla, Anne O’Dea, Jennifer R. Klemp, Monica Kurylo, Abiodun Akinwuntan, Hannes Devos	2018	6
18	Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy Healthcare ·Sean Liebscher, Lyndsey J. Kilgore, Onalisa Winblad, Nika Gloyeske, Kelsey E. Larson, Christa Balanoff, Lauren Nye, Anne O’Dea, Priyanka Sharma, Bruce F. Kimler, Qamar J. Khan, Jamie L. Wagner	2023	4
19	Differential impact of proliferation signature on efficacy of neoadjuvant chemoimmunotherapy in sTIL-high and sTIL-low triple-negative breast cancer (TNBC): Biomarker analysis of the NeoPACT trial. Journal of Clinical Oncology ·Shane R. Stecklein, Rachel Yoder, Joshua M. Staley, Zachary Schmitt, Anne O’Dea, Lauren Nye, Manana Elia, Deepti Satelli, Gregory Crane, Rashna Madan, Maura O’Neil, Andrew K. Godwin, Roberto Salgado, Qamar J. Khan, Joyce O’Shaughnessy, Priyanka Sharma	2023	4
20	Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis JCO Precision Oncology ·Sajjad Akbar Bhatti, Jaimie Heldstab, Carolyn Lehn, Ossama Tawfik, Ryan Ash, David R. Hout, Robert S. Seitz, Daniel Bailey, Anne O’Dea, Roy A. Jensen, Fang Fan, Qamar J. Khan, Andrew K. Godwin, Priyanka Sharma	2017	4

About Anne O’Dea

Anne O’Dea is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 45 papers that have together received 716 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (11 papers), Cancer Genomics and Diagnostics (10 papers), Cancer Treatment and Pharmacology (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Cells and Metastasis (5 papers), HER2/EGFR in Cancer Research (5 papers) and BRCA gene mutations in cancer (5 papers). The work is most often cited by research in Oncology (445 citations), Cancer Research (233 citations), Pathology and Forensic Medicine (133 citations), Pulmonary and Respiratory Medicine (207 citations) and Genetics (106 citations). Anne O’Dea has collaborated with scholars based in United States, Australia and Belgium. Frequent co-authors include Qamar J. Khan, Priyanka Sharma, Bruce F. Kimler, Carol J. Fabian, Jennifer R. Klemp, Pavan S. Reddy, Lauren Nye, Jamie L. Wagner, Christa Balanoff and Kelsey E. Larson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Nature Cancer, International Journal of Radiation Oncology*Biology*Physics and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact